Clinical trial
Oxaliplatin With FOLFOX4 in Patients With Normal and Abnormal Renal Function
NCT00094965 · Sanofi, Industry · Completed
Key facts
| NCT number | NCT00094965 |
|---|---|
| Title | Oxaliplatin With FOLFOX4 in Patients With Normal and Abnormal Renal Function |
| Official title | Phase II Trial of Oxaliplatin in Combination With Bolus/Infusional 5FU/LV (FOLFOX4) in Patients With Advanced Gastrointestinal (GI) Cancers With Varying Degrees of Renal Impairment |
| Acronym | FOLFOX4 |
| Lead sponsor | Sanofi, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Gastrointestinal Cancer |
| Intervention type | Drug |
| Interventions | Oxaliplatin (SR96669) |
| Enrollment | 43 |
| Start date | Sep 1, 2004 |
| Primary completion | Aug 1, 2007 |
| Completion | Aug 1, 2007 |
| First posted | Oct 29, 2004 |
| Last update posted | Mar 30, 2009 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: